Therapeutic mRNA Production Services from Sequence to IND

WuXi Biologics offers extensive development capabilities and GMP manufacturing capacity for mRNA therapeutics and vaccines. Our expert and highly-trained team provides end-to-end services from early-stage development through to initial plasmid DNA manufacturing and on to drug substance (DS) and drug product (DP) GMP production. Our GMP services include a manufacturing facility with up to 300L scale fermenter for plasmid DNA production and 50L volume vessels and purification equipment for mRNA transcription and purification. In addition, state-of-the-art mRNA-LNP production systems and robotic aseptic filling systems are available for DP manufacturing. Like all of our services, the foundation of our mRNA service platform is built upon remarkable in-house, single-source CMC development and manufacturing capabilities and expertise, execution excellence, and our world-class quality system. TIPS: We also provide rapid material generation and high-quality feasibility study services as standalone projects.

WuXi Biologics’ services for mRNA therapeutics and vaccines

Integrated, End-to-end Services from Sequence to IND

Plasmid DNA manufacturing

E. coli strain construction

Plasmid purification

Plasmid DNA

Fermentation

In vitro transcription (Co-capping or post-capping)

mRNA transcription and purification

Key services include: Sequence optimization MCB/WCB creation and testing Process development:

Plasmid DNA linearized template

mRNA purification

mRNA DS

mRNA-LNP formulation

Sterile filtration

LNP encapsulation

TFF

mRNA-LNP

Plasmid DNA: E. coli fermentation, cell lysis and purification mRNA: In Vitro Transcription (IVT) including co-capping or post-capping, purification LNP: encapsulation, UF/DF, fill/finish

DS & DP manufacturing

Stability

mRNA DS

mRNA-LNP

Release

Tech transfer and scale-up GMP manufacturing: DS and DP Comprehensive analytical development and QC testing capability Full CMC and regulatory support

WuXi Biologics services cover all critical CMC processes with a timeline of 8 months from DNA to IND filing.

8 months from DNA to IND filing

1

2

3

4

5

6

7

8

Tox materials release

GMP pDNA release

DNA

GMP mRNA release

GMP mRNA-LNP DP release

Powered by